Clonal evolution and drug resistance: from cancer avatars to liquid biopsies.
Dip. Oncologia UNITO and IFOM
Joined December 2019
- Tweets105
- Following156
- Followers696
- Likes179
Bardelli Lab retweeted
Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer dlvr.it/TM0DWX
Bardelli Lab retweeted
Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models dlvr.it/TM0Npb
Bardelli Lab retweeted
ecDNA fuels cancer progression: large, mobile circles of DNA in tumors drive high oncogene copies & rapid genetic changes. Their random spread during cell division increases treatment resistance & tumor evolution. Determining therapeutic vulnerabilities & identifying target compounds to limit ecDNA evolution could open impactful new therapeutic horizons.
nature.com/articles/s41586-0…
RT @christophertape: Excellent review from @mariangelaruss2 @BardelliLab discussing our current understanding of drug-tolerant persister ce…
Bardelli Lab retweeted
A great overview/update of this burgeoning field! Still a lot of unanswered questions, but exciting time ahead! Happy we could contribute to this field and comprehensive overview. Thanks to @BardelliLab for taking the lead.
Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on @NatureRevCancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives
Persisters: rdcu.be/dSJp4
Bardelli Lab retweeted
📢This week in @NatureRevCancer, a joint effort by many groups led by the @BardelliLab on #Cancer Persister cells.
🙌🏻It’s been a pleasure to contribute to this roadmap.
➡️rdcu.be/dSJp4
Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on @NatureRevCancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives
Persisters: rdcu.be/dSJp4
Bardelli Lab retweeted
Excited to share the #Pezcoller23 Symposium final program, with a tremendous lineup of speakers!
💡 NEW TECHNOLOGIES FOR STUDYING AND TREATING CANCER
🗓️19-20 June 🇮🇹 Trento
⏳ Still few days to register, deadline: 31/05👉 lnkd.in/etYSdNMX
@ESOncology recommended event
Bardelli Lab retweeted
Today at the #EACRCongress in Torino inspiring talk on liquid biopsy and its clinical application by dr. Marsoni. Do not miss upcoming news in the next months!
@EACRnews @eacr2023
Bardelli Lab retweeted
Wonderful talk by Yaara Oren kicking off the session on cancer persisters at #EACR2023. Did you know she trained as microbiologist? Thinking outside the box! @EACRnews @BardelliLab
Bardelli Lab retweeted
Amazing overview of the last ten years of research in colorectal cancer pointing towards new exciting ones by Prof. Bardelli at #EACR2023.
@BardelliLab @EACRnews
Bardelli Lab retweeted
Great lecture of @Albert0Bardelli @BardelliLab yesterday at @EACRnews meeting explaining how targeting of MLH1 and temozolamide treatment can engage #immunotherapy response in #coloncancer
Bardelli Lab retweeted
Huge congratulations to EACR Board member Carlos Caldas on this award! @CaldasLab 🥳
Carlos was awarded the @FondationARC Léopold Griffuel Award at the European Parliament in Strasbourg today: "I stand on the shoulders of my amazing laboratory group. I share this enormous honour with all of them!"
Look forward to his talk at #EACR2023 on 13/6 at 4.30 pm!
#bcsm
Day 3 begins with a great talk by #ChiaraCattaneo on "Dissecting Tumor-immune Cells Interactions: Functional Models for Individual Patients".
@EACRnews @IFOMresearch #EACR2023
Bardelli Lab retweeted
Today at #EACR2023 Giovanni Crisafulli just presented new super interesting data on T-cell repertoire after temozolomide treatment from the #Arethusatrial patients. What’s next from this proof-of-concept trial? Stay tuned!
@BardelliLab @EACRnews @eacr2023
It is always a pleasure to watch past students of our lab to fligh high as scientists!
Great #GiuliaLerda! Great talk!
@EACRnews
If you are interested in our work..join our group!!! We have open positions!!!#hiring #HIRINGNOW
Great start of day 2 at #EACR2023 with drug resistance session, wonderful talk by @mariangelaruss2 from @BardelliLab on innovative concepts in cancer persisters evolution and new approaches to eradicate them exploiting DNA damage and DDR inhibitors! Exciting science @EACRnews
